Applied Molecular Transport Financial Statements (AMTI)

Applied Molecular Transportsmart-lab.ru %   2022Q3 2022Q4 2023Q1 2023Q2 2023Q3   LTM ?
Report date 07.11.2022 09.03.2023 11.05.2023 14.08.2023 09.11.2023   09.11.2023
Currency USD USD USD USD USD   USD
Financial report URL  
Revenue, bln rub ? 0.000 0.000 0.000 0.000 0.000   0.000
Operating Income, bln rub -25.5 -23.1 -28.5 -17.7 -7.22   -76.5
EBITDA, bln rub ? -25.5 -23.1 -11.0 -1.47 -7.22   -42.8
Net profit, bln rub ? -24.9 -22.1 -26.8 -17.3 -6.94   -73.1
OCF, bln rub ? -19.6 -14.8 -19.3 -21.5 -4.40   -60.0
CAPEX, bln rub ? 0.223 0.006 0.061 0.385 0.000   0.452
FCF, bln rub ? -19.8 -14.8 -19.4 -21.9 -4.40   -60.5
Dividend payout, bln rub 0.000 0.000 0.000 0.000 0.000   0.000
Ordinary share dividend yield, % 0.00% 0.00% 0.00% 0.00% 0.00%   0.00%
Dividend payout ratio, % 0.00% 0.00% 0.00% 0.00% 0.00%   0
OPEX, bln rub 25.5 23.1 19.7 9.60 7.26   59.7
Cost of production, bln rub 0.000 0.000 0.000 0.000 0.000   0.000
R&D, bln rub 18.2 14.4 13.0 2.56 0.250   30.2
Interest expenses, bln rub 0.321 0.393 0.579 0.000 0.000   0.972
Assets, bln rub 124.6 107.4 83.3 25.0 20.0   20.0
Net Assets, bln rub ? 78.4 60.8 36.1 20.6 16.2   16.2
Debt, bln rub 36.6 36.1 35.0 1.71 1.35   1.35
Cash, bln rub 76.0 61.1 41.8 22.5 18.1   18.1
Net debt, bln rub -39.5 -25.0 -6.73 -20.7 -16.8   -16.8
Ordinary share price, rub 0.973 0.420 0.320 0.258 0.157   0.140
Number of ordinary shares, mln 38.9 39.0 39.2 39.3 39.8   39.8
Market cap, bln rub 38 16 13 10 6   6
EV, bln rub ? -2 -9 6 -11 -11   -11
Book value, bln rub 78 61 36 21 16   16
EPS, rub ? -0.64 -0.57 -0.68 -0.44 -0.17   -1.84
FCF/share, rub -0.51 -0.38 -0.49 -0.56 -0.11   -1.52
BV/share, rub 2.01 1.56 0.92 0.52 0.41   0.41
FCF yield, % ? -281.7% -598.0% -675.9% -747.7% -969.2%   -1 087%
ROE, % ? -170.3% -206.2% -303.3% -441.2% -450.4%   -450.4%
ROA, % ? -107.2% -116.7% -131.6% -365.0% -365.5%   -365.5%
P/E ? -0.28 -0.13 -0.11 -0.11 -0.09   -0.08
P/FCF -0.35 -0.17 -0.15 -0.13 -0.10   -0.09
P/BV ? 0.48 0.27 0.35 0.49 0.38   0.34
EV/EBITDA ? 0.01 0.07 -0.06 0.17 0.25   0.26
Debt/EBITDA 0.30 0.20 0.07 0.34 0.39   0.39
R&D/CAPEX, % 8 178% 240 667% 21 292% 664.4%   6 689%
Applied Molecular Transport shareholders